Darius Desai

[Darius Desai @darius_desai]

@SyedAAhmad5 @jama Nice. I see you got a Ph.D too!!

[Darius Desai @darius_desai]

@SyedAAhmad5 @Colts @DukeFOOTBALL @Daniel_Jones10 @rileyleonard13_ How about US presidents and super bowl winning coaches?

[Darius Desai @darius_desai]

@SyedAAhmad5 Pink Floyd even though most would say The Who.

[Flavio G Rocha, MD, FACS, FSSO @FlavioRochaMD]

Dose density 🔋 in #neoadjuvant Tx for #PDAC
A landmark analysis of @SWOG S1505
DD >85% pre or DD >70% periop ➡️OS benefit
Kudos 👏🏽 to investigators and lead author
Dr. Sameer Patel @UCincySurg
@SyedAAhmad5 @DavendraSohal
@OHSUKnight @OHSUpancreatic

https://t.co/cNqFsZE3xm

[Julie Hallet @HalletJulie]

Less 🩸transfusions for hepatectomy

Multicentre RCT 🇨🇦 by @ChamoGui
👥 446 pts
Phlebotomy 🆚 usual care

⤵️🩸transfusion 16 to 8%
NNT 11 😀
No change in complications

Towards a new standard of care?

📝🔗 https://t.co/Nw4C9Qy2g5 @LancetGastroHep

[Society of Surgical Oncology @SocSurgOnc]

New insights into G2 pancreatic neuroendocrine tumors! Subgrading G2a (Ki67 <10%) vs. G2b (10–20%) reveals distinct behaviors, with G2b showing metastatic potential akin to G3. Read more in @AnnSurgOncol: https://t.co/SLK8vDkJxt #FeaturedArticle

[Darius Desai @darius_desai]

@DrBonillaOnc @mystlukes @templemedschool Welcome. Looking forward to working with you.

[Darius Desai @darius_desai]

@SyedAAhmad5 @Bengals @onepeloton If this is frustrating you, you must have done a 200 mile workout after the OSU game. I am still annoyed. My boys took it easy on me though.

[Syed A. Ahmad @SyedAAhmad5]

Survival Outcomes of an Early Intervention Smoking Cessation Treatment After a Cancer Diagnosis ⁦@JAMAOnc⁩ https://t.co/oQuIbovVhi

[Darius Desai @darius_desai]

@SyedAAhmad5 Without a doubt, this is your favorite little vein.

[Tim Miller @Timodc]

In which @BillKristol makes a direct appeal to the Trump-curious in his life in light of the debate.

"Do you honestly believe this man can and should lead the country for the next four years?"

https://t.co/qXLOIfrxtz

[Syed A. Ahmad @SyedAAhmad5]

Value of Surgical Cytoreduction in Patients with Small Intestinal Neuroendocrine Tumors Metastatic to the Liver and Peritoneum ⁦@AnnSurgOncol⁩ https://t.co/K6vlQnyQ7h

[Thor Halfdanarson @OncoThor]

Observation of small (≤2cm) panc NETs is widely accepted and becoming a standard. Maybe it is a little more nuanced... Should we take into account tumor grade as well as stage re resection? Small G2 pNETs are more likely than G1 to be N+ (15% vs. 3%).

https://t.co/YFsPYO8Drq

[Darius Desai @darius_desai]

@SyedAAhmad5 @elliotthaut @VascSurgMD I remember the 5am walk rounds with him. One of a kind.

[Jash Datta, MD @DrJashDatta]

Proud to be co-awarded this @TheVFoundation Translational Research Grant (co-sponsored by @MiamiDolphins) & work closely w/ the superbly talented @PeterHoseinMD. We will uncover an enigmatic mechanism of immunotherapy sensitivity in gHRD mutant #PancreaticCancer #pancsm Let’s go!

[Mark Yarchoan @MarkYarchoan]

Most impressive data from #CheckMate9DW (frontline nivo/ipi in #HCC) is the median duration of response: 30.4 months❗️Reaffirms something we've seen time and time again⏩Anti-CTLA4 responses are the most durable

[Darius Desai @darius_desai]

@FoxChaseCancer @BarrakDany @JeffreyFarma Congratulations

[Surgical Oncology Insight @SurgOncInsight]

New! In press: Prognostic Role of Post-operative #cfDNA after Resection of #ColorectalLiverMetastases: #SystematicReview and #MetaAnalysis . @BeninatoToni @mariameskmd @MiralGrandhiMD @HInMD @RCLanganMD @HenryPittMD @skmaithel https://t.co/BdYMgtKEfN

[Arndt Vogel @ArndtVogel]

🔥ctDNA dynamics in CRC with molecular residual disease
🔎Updated analysis from GALAXY, 2998 pts
👉ctDNA+ post-OP (14%) highly prognostic --> 2yr -OS 29% vs 86%
👉ctDNA clearence --> >90% DFS
🧐Supports ctDNA guided adj. treatment strategies
@myESMO

[Krishan Jethwa @KrishanJethwa]

🚨🚨🚨
Rectal Cancer Tweetorial!!

Rectal cancer is a highly heterogeneous disease with rapid evolution in practice.

Let's review current data to generate a pragmatic, patient-centric, approach to management!
#GI24 #GIonc #RadOnc

Thank you @ASCO for the opportunity!🙏🏽

1/